EBIXA 10 mg, film-coated tablet 56 tablets
Brand page: Ebixa (memantine) — all forms and strengths in France
Active ingredients: Memantine hydrochloride, Memantine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- EBIXA 10 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium polypropylène de 56 comprimé(s)
- Marketing authorisation holder
- LUNDBECK (DANEMARK)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 11 Aug 2003
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64898084CIP73595531CIP133400935955319Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE MÉMANTINEcomprimé | 10 mg · un comprimé | SA |
| MÉMANTINE BASEcomprimé | 8,31 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.